JP2020513004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513004A5 JP2020513004A5 JP2019554738A JP2019554738A JP2020513004A5 JP 2020513004 A5 JP2020513004 A5 JP 2020513004A5 JP 2019554738 A JP2019554738 A JP 2019554738A JP 2019554738 A JP2019554738 A JP 2019554738A JP 2020513004 A5 JP2020513004 A5 JP 2020513004A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- composition according
- acid
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482134P | 2017-04-05 | 2017-04-05 | |
| US62/482,134 | 2017-04-05 | ||
| PCT/US2018/026091 WO2018187473A1 (en) | 2017-04-05 | 2018-04-04 | Methods and compositions for treating retina-associated disease using ccr3-inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513004A JP2020513004A (ja) | 2020-04-30 |
| JP2020513004A5 true JP2020513004A5 (cg-RX-API-DMAC7.html) | 2021-05-13 |
| JP7179755B2 JP7179755B2 (ja) | 2022-11-29 |
Family
ID=62067800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554738A Active JP7179755B2 (ja) | 2017-04-05 | 2018-04-04 | Ccr3阻害剤を使用した網膜関連疾患を治療するための方法および組成物 |
Country Status (20)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11382907B2 (en) * | 2017-04-05 | 2022-07-12 | Alkahest, Inc. | Methods and compositions for treating aging-associated impairments using CCR3-inhibitors |
| EP3856195A4 (en) * | 2018-09-26 | 2022-06-22 | Alkahest, Inc. | METHODS AND COMPOSITIONS FOR TREATMENT OF AGING-RELATED DISORDERS USING CCR3 INHIBITORS |
| US12692301B2 (en) * | 2020-06-11 | 2026-07-28 | Alkahest Inc. | Methods of improving retina-associated disease outcome using CCR3-inhibitors |
| CN112322719A (zh) * | 2020-11-06 | 2021-02-05 | 温州医科大学 | 循环血外泌体miRNA作为视网膜静脉阻塞疾病诊断标志物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2002112800A (ru) | 2002-05-16 | 2004-03-10 | Евгений Ильич Зарайский (RU) | Способ лечения диабетической ретинопатии |
| US8008092B2 (en) | 2007-10-09 | 2011-08-30 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
| US8278302B2 (en) * | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| UA109290C2 (uk) * | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| US20140335083A1 (en) | 2011-12-01 | 2014-11-13 | Glaxo Group Limited | Methods of treatment and prevention of eye diseases |
| AR090566A1 (es) | 2012-04-02 | 2014-11-19 | Boehringer Ingelheim Int | Proceso para la produccion de inhibidores de crr |
| US20130261153A1 (en) * | 2012-04-03 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Use of ccr3-inhibitors |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
| US11382907B2 (en) | 2017-04-05 | 2022-07-12 | Alkahest, Inc. | Methods and compositions for treating aging-associated impairments using CCR3-inhibitors |
-
2018
- 2018-04-04 EA EA201992356A patent/EA201992356A1/ru unknown
- 2018-04-04 EP EP18720836.8A patent/EP3606521B1/en active Active
- 2018-04-04 JP JP2019554738A patent/JP7179755B2/ja active Active
- 2018-04-04 KR KR1020197032819A patent/KR102658724B1/ko active Active
- 2018-04-04 WO PCT/US2018/026091 patent/WO2018187473A1/en not_active Ceased
- 2018-04-04 UA UAA201910857A patent/UA125658C2/uk unknown
- 2018-04-04 SG SG11201909207V patent/SG11201909207VA/en unknown
- 2018-04-04 CN CN201880023759.8A patent/CN110650740A/zh active Pending
- 2018-04-04 US US16/603,084 patent/US11590118B2/en active Active
- 2018-04-04 ES ES18720836T patent/ES2950453T3/es active Active
- 2018-04-04 IL IL269743A patent/IL269743B/en unknown
- 2018-04-04 CA CA3058654A patent/CA3058654A1/en active Pending
- 2018-04-04 EP EP23168381.4A patent/EP4245295B1/en active Active
- 2018-04-04 BR BR112019020430-0A patent/BR112019020430A2/pt not_active IP Right Cessation
- 2018-04-04 AU AU2018248425A patent/AU2018248425B2/en active Active
- 2018-04-04 MX MX2019012012A patent/MX394915B/es unknown
- 2018-04-04 NZ NZ757769A patent/NZ757769A/en unknown
- 2018-04-04 MY MYPI2019005833A patent/MY199462A/en unknown
- 2018-04-04 ES ES23168381T patent/ES3046717T3/es active Active
- 2018-04-09 TW TW107112125A patent/TW201841636A/zh unknown
-
2019
- 2019-10-04 CL CL2019002839A patent/CL2019002839A1/es unknown
- 2019-11-01 CO CONC2019/0012336A patent/CO2019012336A2/es unknown
-
2023
- 2023-02-16 US US18/170,384 patent/US11951102B2/en active Active
-
2024
- 2024-06-18 AU AU2024204133A patent/AU2024204133B2/en active Active